Molsid

Executive Summary

Molsid is a French biotechnology company specializing in fluorogenic molecular probes and diagnostic kits for rapid enzyme activity detection, primarily targeting antimicrobial resistance (AMR). Founded in 2017 and based in Lyon, the company aims to provide healthcare professionals with fast, accurate diagnostic tools to guide effective patient care and combat the growing threat of AMR. Molsid's innovative platform leverages small molecule probes that generate a fluorescent signal upon interaction with specific enzymes, enabling real-time detection of resistance mechanisms. This technology has potential applications in clinical diagnostics, infection control, and antibiotic stewardship programs. As a private company with no disclosed funding or valuation, Molsid operates in the competitive diagnostics space, but its focus on unmet needs in AMR positions it well for growth if it can secure regulatory approvals and commercial partnerships.

Upcoming Catalysts (preview)

• Q3 2026CE Marking for Lead Diagnostic Kit60% success
• Q4 2026Series A Funding Round70% success
• H1 2027Strategic Partnership with Diagnostics Company50% success